NDC 63323-721

Bortezomib

Bortezomib

Bortezomib is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Bortezomib.

Product ID63323-721_5620c54f-596e-4f92-87b0-bd6f4b55a019
NDC63323-721
Product TypeHuman Prescription Drug
Proprietary NameBortezomib
Generic NameBortezomib
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2017-11-06
Marketing CategoryNDA / NDA
Application NumberNDA205004
Labeler NameFresenius Kabi USA, LLC
Substance NameBORTEZOMIB
Active Ingredient Strength1 mg/mL
Pharm ClassesProteasome Inhibitor [EPC],Proteasome Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 63323-721-10

1 VIAL, SINGLE-DOSE in 1 CARTON (63323-721-10) > 10 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2017-11-06
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63323-721-10 [63323072110]

Bortezomib INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA205004
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-11-06

Drug Details

Active Ingredients

IngredientStrength
BORTEZOMIB1 mg/mL

OpenFDA Data

SPL SET ID:042329d6-8077-4af2-816f-cd0a2bbcbbd3
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 402243
  • UPC Code
  • 0363323721107
  • Pharmacological Class

    • Proteasome Inhibitor [EPC]
    • Proteasome Inhibitors [MoA]

    NDC Crossover Matching brand name "Bortezomib" or generic name "Bortezomib"

    NDCBrand NameGeneric Name
    0143-9098bortezomibbortezomib
    0409-1700BortezomibBortezomib
    0409-1703BORTEZOMIBBORTEZOMIB
    0409-1704BORTEZOMIBBORTEZOMIB
    0781-3258bortezomibbortezomib for injection
    10019-991BORTEZOMIBbortezomib
    25021-244BORTEZOMIBBORTEZOMIB
    43598-426BortezomibBortexomib
    43598-865BortezomibBortexomib
    50742-484BortezomibBortezomib
    51817-586Bortezomibbortezomib
    55150-337BORTEZOMIBBORTEZOMIB
    60505-6050BORTEZOMIBbortezomib
    63323-721BortezomibBortezomib
    63323-821BortezomibBortezomib
    67184-0530BortezomibBortezomib
    68001-534BortezomibBortezomib
    68001-540BortezomibBortezomib
    68001-541BortezomibBortezomib
    70511-161Bortezomibbortezomib
    70511-162Bortezomibbortezomib
    70710-1411BORTEZOMIBBORTEZOMIB
    70771-1708BORTEZOMIBBORTEZOMIB
    70860-225Bortezomibbortezomib
    71288-118BortezomibBortezomib
    72205-183BortezomibBortezomib
    72266-243Bortezomibbortezomib
    72266-244Bortezomibbortezomib
    63020-049VELCADEbortezomib

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.